RT Journal Article
SR Electronic
T1 Bilateral sequential lung transplantation for end stage septic lung disease.
JF Thorax
JO Thorax
FD BMJ Publishing Group Ltd and British Thoracic Society
SP 565
OP 566
DO 10.1136/thx.50.5.565
VO 50
IS 5
A1 A Hasan
A1 P A Corris
A1 M Healy
A1 N Wrightson
A1 A D Gascoigne
A1 D A Waller
A1 I Wilson
A1 C J Hilton
A1 F K Gould
A1 J Forty
YR 1995
UL http://thorax.bmj.com/content/50/5/565.abstract
AB BACKGROUND-- Bilateral sequential lung transplantation (BSLT) has been widely adopted as an alternative to combined heart and lung transplantation for the management of end stage septic lung disease in many transplant centres. METHODS-- A retrospective review was undertaken of the first 32 consecutive patients with septic lung disease to undergo BSLT at the Freeman Hospital. RESULTS-- Between April 1988 and October 1994 32 patients underwent BSLT. Survival at 30 days was 85% and actuarial survival at one year was 70%. Improved pulmonary function was seen in all surviving patients. CONCLUSION-- BSLT for septic lung disease offers comparable survival to heart-lung transplantation, with excellent functional results. Long term results may be superior because the disadvantages of transplanting the heart are avoided.